Health :: Food Safety Consortium Summarizes Year’s Work

Multiple research projects across three cooperating universities are demonstrating progress that is enabling American producers, processors and consumers to maintain a safe food supply. The Food Safety Consortium summarized that work in its recently completed annual report for the 2005-06 fiscal year.

Parenting :: Traditional books provide more positive parent-child interaction

Parents and pre-school children have a more positive interaction when sharing a reading experience with a traditional book as opposed to an electronic book or e-book, according researchers at Temple University’s Infant Laboratory and Erikson Institute in Chicago. This shared positive experience from traditional books characteristically promotes early literacy skills.

Ecology :: ESSP launches new Monsoon Asia Integrated Regional Study

The Earth System Science Partnership (ESSP) has recently launched a Monsoon Asia Integrated Regional Study (MAIRS) and will share details of the study, as well as outline research needs and knowledge gaps in the understanding of Monsoon Asia, during several special sessions at the ESSP Open Science Conference.

Health :: Agenda Items for the 38th Session of the Codex Committee on Food Hygiene

The Office of the Under Secretary for Food Safety, U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services announced a public meeting to provide information and receive public comments on agenda items and draft U.S. positions for the 38th Session of the Codex Committee on Food Hygiene (CCFH), to be held Dec. 4 – 9, in Houston, Texas.

Health :: FDA issues approvable letter for Entereg for POI

GlaxoSmithKline (NYSE: GSK) and Adolor Corporation (Nasdaq: ADLR) announced that the Food and Drug Administration (FDA) has issued a letter stating that the new drug application (NDA) for Entereg (alvimopan 12mg) for the management of post operative ileus (POI) is approvable. The FDA has requested 12-month safety data, including analysis of serious cardiovascular events, from study 014 (767905/014), an ongoing safety study in opioid-induced bowel dysfunction (OBD). The FDA also requested a risk management plan as part of the submission.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack